A case study in pharma chilling and freezing

Copywrite Ceva-Phylaxia 2

This week’s free feature on 23/09/19For French animal vaccine producer Ceva-Phylaxia, cryogenics technology plays a significant role in its day-to-day business. The company produces live, as well as inactivated, viral and bacterial vaccines across its 13 R&D centres and 23 production sites in 44 countries around the globe, which need ...

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World

 

Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content from just $250 per annum, or if you are only interested in North American content, pay just $190!